veliparib,pembrolizumab
merck,abbvie
[]
long-term results from nrg-gi002: a phase ii clinical trial platform using total neoadjuvant therapy (tnt) in locally advanced rectal cancer (larc).
talk by dr #gi23 #crcsm
negative trial, but great platform for testing agents in larc 
Pt Adv, NCI Rectal Anal TF
Mom, lifelong learner
Wants to bring patient voice to research, clinical trials & more!
Check out @CRCTrialsChat
1st love: Virology